Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and potential therapeutics

Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and potential therapeutics

The emergence of a new coronavirus, in around late December 2019 which had first been reported in Wuhan, China has now developed into a massive threat to global public health. The World Health Organization (WHO) has named the disease caused by the virus as COVID-19 and the virus which is the culprit...

Full description

Bibliographic Details
Main Authors: Ahmad, B. (Author), Benchoula, K. (Author), Chong, P.P (Author), Mea, H.J (Author), Palanisamy, N.K (Author), Saleemi, M.A (Author), Vohra, M.S (Author), Wong, E.H (Author)
Format: Article
Language:English
Published: Elsevier B.V., 2020
Subjects:
Antiviral Agents
antivirus agent
cardiomyopathy
CD4+ T lymphocyte
CD8+ T lymphocyte
China
chloroquine
classification
coronavirus disease 2019
COVID-19
drug choice
drug efficacy
drug repositioning
Drug Repositioning
drug research
drug targeting
genetics
hepatitis B
HIV
HIV Infections
human
Human immunodeficiency virus
Human immunodeficiency virus infection
Humans
immunology
lopinavir plus ritonavir
malaria
Middle East respiratory syndrome
Molecular mechanisms
nonhuman
Origin and taxonomy
pandemic
Pandemics
pathogenesis
phylogeny
Phylogeny
Potential therapeutics
priority journal
recombinant alpha2b interferon
remdesivir
Review
ribavirin
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
taxonomy
viral genetics
virology
virus cell interaction
virus morphology
virus transmission
Online Access:View Fulltext in Publisher
View in Scopus

Internet

View Fulltext in Publisher
View in Scopus

Similar Items